Ikeda M - Search Results

1

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.

Kato N, Kudo M, Tsuchiya K, Hagihara A, Numata K, Aikata H, Inaba Y, Kondo S, Motomura K, Okano N, Ikeda M, Morimoto M, Kuroda S, Kimura A. Kato N, et al. Among authors: ikeda m. Hepatol Res. 2023 May;53(5):409-416. doi: 10.1111/hepr.13876. Epub 2023 Jan 23. Hepatol Res. 2023. PMID: 36601972

2

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.

Kuriyama H, Okada S, Okusaka T, Ueno H, Ikeda M. Kuriyama H, et al. Among authors: ikeda m. J Gastroenterol Hepatol. 2002 Nov;17(11):1205-10. doi: 10.1046/j.1440-1746.2002.02807.x. J Gastroenterol Hepatol. 2002. PMID: 12453281

3

Spontaneous regression of hepatocellular carcinoma.

Kondo S, Okusaka T, Ueno H, Ikeda M, Morizane C. Kondo S, et al. Among authors: ikeda m. Int J Clin Oncol. 2006 Oct;11(5):407-11. doi: 10.1007/s10147-006-0591-4. Int J Clin Oncol. 2006. PMID: 17058140

4

A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.

Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Ogura T, Hagihara A, Iwasa S. Tanaka T, et al. Among authors: ikeda m. Cancer Chemother Pharmacol. 2008 Apr;61(4):683-8. doi: 10.1007/s00280-007-0523-7. Epub 2007 May 31. Cancer Chemother Pharmacol. 2008. PMID: 17541589 Clinical Trial.

5

Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Ikeda M, Morizane C, Ogura T, Hagihara A, Tanaka T. Ueno H, et al. Among authors: ikeda m. Jpn J Clin Oncol. 2007 Jul;37(7):515-20. doi: 10.1093/jjco/hym060. Epub 2007 Aug 2. Jpn J Clin Oncol. 2007. PMID: 17675286 Clinical Trial.

6

Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.

Ikeda M, Okusaka T, Ueno H, Morizane C, Iwasa S, Hagihara A, Kojima Y. Ikeda M, et al. Oncology. 2007;72(3-4):188-93. doi: 10.1159/000112805. Epub 2007 Dec 20. Oncology. 2007. PMID: 18097170

7

Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Morizane C, Kojima Y, Iwasa S, Hagihara A. Ikeda M, et al. Jpn J Clin Oncol. 2008 Oct;38(10):675-82. doi: 10.1093/jjco/hyn087. Epub 2008 Aug 20. Jpn J Clin Oncol. 2008. PMID: 18716041

8

Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.

Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Hagihara A, Iwasa S, Kojima Y. Tanaka T, et al. Among authors: ikeda m. Jpn J Clin Oncol. 2008 Nov;38(11):755-61. doi: 10.1093/jjco/hyn098. Epub 2008 Oct 8. Jpn J Clin Oncol. 2008. PMID: 18845521

9

Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

Hashimoto K, Ueno H, Ikeda M, Kojima Y, Hagihara A, Kondo S, Morizane C, Okusaka T. Hashimoto K, et al. Among authors: ikeda m. Oncology. 2009;77(3-4):217-23. doi: 10.1159/000236022. Epub 2009 Sep 4. Oncology. 2009. PMID: 19729980

10

Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.

Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, Tanaka T, Nakachi K, Mitsunaga S, Kojima Y, Hagihara A, Hiraoka N. Iwasa S, et al. Among authors: ikeda m. Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4. Jpn J Clin Oncol. 2010. PMID: 20047862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,520 results

Search Page